Meta Health Expands with Jas Medical Acquisition

Meta Health Limited (SG:5DX) has released an update.

Meta Health Limited has expanded its stake in Jas Medical Screening Centre by acquiring 55% of its share capital. This acquisition involved the allotment of 23,331,000 Consideration Shares and 2,133,240 Initial Introducer Shares, increasing the company’s total issued shares to over 1 billion. The new shares are set to be listed on the Catalist of the SGX-ST, broadening Meta Health’s presence in the medical sector.

For further insights into SG:5DX stock, check out TipRanks’ Stock Analysis page.